4572 Carna Biosciences
- 415
- 00.00%
Carna Biosciences News
Emerging Markets Digest: PSS continued to decline significantly for the third day, while Dricom reached its daily limit.
<7707> PSS 376 -34, significantly down for the third consecutive day. Tokyo Stock Exchange strengthened regulatory measures on margin trading from the 28th, causing bearish sentiment and leading to selling pressure. The initial margin requirement for new sell and buy orders is set at 70% or higher (with cash portion over 40%). Japan Securities Finance is also enhancing collateral collection measures. Precision System Science disclosed on the 27th that they have started selling PCR reagents manufactured by the German company SMD GmbH in the domestic market, but until the buying interest shifts.
Hot stocks digest (morning session): Rakuten Group, Hirata Corporation, Japan Air Conditioning, etc.
rakuten <4755>: 1027 yen (+85.1 yen) significant rise. morgan stanley MUFG securities continues to determine investment as overweight, raising the target stock price from 1100 yen to 1300 yen. If the business value of mobile is realized, the possibility of achieving a stock price of 1500 yen also increases. Expansion of acquiring contracts as main lines from corporate contracts, expanding main line ratio is expected to increase ARPU with a time lag, and the mobile business is for the fiscal year ending December 2026.
CarnaBio - failed to extend and fell back, the new lipid kinase DGKα inhibitor program has been patented in the european index.
The stock fell without reaching its peak. Carna Biosciences announced that it has received a patent evaluation from the European Patent Office for a patent jointly filed with Gilead Sciences, its derivation destination, related to a new lipid kinase DGKα inhibitor program created by Carna Biosciences. In addition to receiving milestone payments from Gilead Sciences based on the development progress and market launch of the pharmaceuticals, Carna Biosciences is also entitled to receive royalties based on the revenue after the pharmaceuticals are launched.
Volume change rate ranking (9 o'clock) - Excizer, S Science, etc. ranked in.
In the volume change rate ranking, you can understand the interest of market participants such as trends in speculations by comparing the volume of the most recent 5 days with the volume on the day of distribution. Top volume change rate [as of 9:32 on August 28] (comparison of volume for the most recent 5 days) Stock Code Stock Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <4392> FIG 2146600 107185.08 286.94% -0.0
The market is weak, making it easier to sell on the rebound, but there is strong support at the lower level.
[Emerging Markets Individual Stock Strategy] Today, a weaker trend is expected in emerging markets. In the US stock market on the 27th yesterday, the Dow Jones average rose by $9.98 (+0.02%) to $41,250.50, slightly extending for the third consecutive day. The rise in long-term interest rates weighed on stock prices, while the unexpected improvement in the August consumer confidence index supported stock prices. In addition, with Nvidia's (NVDA) earnings report scheduled for the 28th, the high tech sector turned higher on expectations, supporting the market. The Dow reached an all-time high for consecutive days.
Carna Biosciences: Confirmatory letter.
Carna Biosciences: Interim report - 22nd term (January 1, 2024 - December 31, 2024)
Honda's operating profit in Q1 increased by 22.9%, reaching 484.7 billion yen.
Honda (7267) announced its first quarter results for the fiscal year ending in March 2025, with sales revenue of 5 trillion 404.858 billion yen, a year-on-year increase of 16.9%, and operating profit of 484.705 billion yen, a year-on-year increase of 22.9%. This exceeded the consensus (around 473 billion yen). The global number of passenger carried increased mainly in India and Brazil in the motorcycle business. The strong sales of hybrid models also continued in the four-wheel business. [Positive evaluation] 5858 STG, 79.
Carna Biosciences: Financial results presentation materials for the second quarter of the December 2024 period.
Carna Biosciences: 2nd quarter (interim period) financial statements as of December 2024 (Japanese standard) (consolidated)
Daiwa House, Mazda, NTT, Softbank Group (7th)
※The above calendar is tentative and subject to change due to company circumstances. --------------------------------------- August 7th (Wednesday) <1451> KHC <1719> Ando Hazama <1720> Tokyu Construction <1726> BRHD <1762> Takamatsu G <1833> Okumura Group <1835> Tokei Kogyo <1890> Toyo Construction <189
Stocks that moved the day before Part 2: Kura Sushi, GMO-AP, Daun, etc.
Brand name <code> 28th closing price ⇒ Previous day comparison Kura Sushi <2695> 4045-300 Negative view of the consolidated interim settlement of its subsidiary Yonago. Hino Motors <7205> 418.0-24.0 UBS Securities downgrades investment judgment. M & A Soken <9552> 4015-285 awareness of one-round feeling even with the movement of the rebound. Kose <4922> 10235-385 coverage started with a target of 10,000 yen at Jefferies Securities. Hokkaido Electric Utilities <9509> 1194-33.
Steady, supported by the long-term decline of US treasury yields, but faces resistance in the upper range.
[Emerging Markets Individual Stock Strategies] Today's emerging markets are expected to show a strong performance. In the U.S. stock market on the 27th yesterday, the Dow Jones Industrial Average continued to rise slightly, up 36.26 points (+0.09%) to 39,164.06 points. After lackluster earnings from companies such as Micron, there were doubts about the sustainability of the artificial intelligence (ai) boom, which weighed on stock prices. On the other hand, buying continued for major high-tech stocks such as Amazon.com, which reached a market capitalization of 2 trillion dollars the day before, and Apple, supporting the market.
Stocks that moved the day before part 2: IseChemical Industrial, AHC Group, DI System, etc.
Stock name <code>19-day closing price ⇒ Previous day comparison K&O Energy Group <1663> 3510 -285 Negative view also on Ise Chemical's stock price decline. Shiseido <4911> 4681 -234 Also viewed negatively due to Bain survey showing China's wealthy restraint in buying. Trend Micro <4704> 6359 -304 Cautious of easing supply and demand in the near term due to the end of share buybacks. Zensho Holdings <7550> 5903 -214 No new material observed, but dislike of slowness of return in the low range.
Active and newly listed stocks during the morning session.
*Fujita Kanko <9722> 8030 +910 is rapidly rising due to the increasing speculation of reorganization. *Unichika <3103> 294 +26 is moving up without any particular material. *Mitsubishi Motors <7211> 456 +38.3 is reported to be expanding its shareholder return policy. *M&A Soken <9552> 3590 +220 continues to rebound from a bottoming out feeling. *Yamashin Filter <6240> 404 +24 has also filled the gap from May at once. *Tokyo Sangyo <
Stocks that moved the previous day part 1: Sellable online advertisements, Fujita Kanko, landowners, etc.
Stock name <code> 18 day closing price ⇒ Trace OP <6696> 685 +71 announced that temporary measures for margin trading restrictions have been lifted. Announced the start of comprehensive partnership with FIG <4392> 340 +10pluszero <5132>. Sellable net advertising <9235> 2315 +212 announced the implementation of shareholder benefits for its first anniversary of listing. Recovery <9214> 1493 +78 announced a share buyback limit of 4.95% of the issued shares. PSOL <4450> 3100 +
Emerging markets stock digest: TraceOP temporarily reached the limit up, Cocopeli soared.
<4068> Basis 1217 + 37 sharply rose. After the end of trading on the 17th, it announced a share buyback. The total number of shares that can be acquired is 26,000 shares (1.39% of the total number of issued shares (excluding treasury stock)), and the total acquisition price is capped at 30 million yen. The acquisition period is from June 18th to December 18th, considering the financial and stock price situation, and enabling flexible capital policy according to changes in the business environment, etc.
Active and newly established stocks in the afternoon session.
-Trace OP (6696) 685 +71. Temporary measures for credit regulations have been lifted. -FIG (4392) 340 +10 announced the start of a comprehensive partnership with pluszero (5132). -Ureru Net Advertising (9235) 2315 +212 announced the implementation of shareholder benefits for the 1st anniversary of its listing. -Recovery (9214) 1493 +78 announced a share buyback of up to 4.95% of the outstanding shares. -PSOL (4450) 3100 +1001 will split one share into two.
Hot stocks digest (morning session): Fujita Kanko, Jishu, Carna Bio, etc.
TDK <6762>: ¥9,503 (+¥640) rebounded significantly. It is reported that the newly developed material for solid state batteries is considered a buy signal. By using it as the "electrolyte", which is important for storage capacity, the energy density of the rechargeable battery appears to be 100 times higher than that of conventional products. It is expected to be installed in small devices such as smart watches and hearing aids, and is scheduled to ship samples as early as 2025. The new material is said to be an oxide-based material. Yaman <
CarnaBio announced the results of the phase 1b clinical trial of AS-1763, which has surged.
AS-1763, the next-generation BTK inhibitor, has surged due to the promising initial data from its Phase 1b clinical trial targeting mature B-cell tumors presented at the 2024 European Hematology Association (EHA). The Phase 1b trial of AS-1763, which is currently ongoing, announced initial data including a promising tumor shrinkage effect for mature B-cell tumor patients with a history of multiple prior treatments, as well as AS-1763's good safety and pharmacokinetic profiles.
Analysis
Price Target
No Data
